Literature DB >> 3059933

Modulation of mesolimbic dopaminergic behaviors by cholecystokinin.

J N Crawley1.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3059933     DOI: 10.1111/j.1749-6632.1988.tb42121.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine.

Authors:  W D Essman; P McGonigle; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Paola Moreno; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2015-03-12       Impact factor: 3.444

3.  Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.

Authors:  Samuel B Kombian; Kethireddy V V Ananthalakshmi; Subramanian S Parvathy; Wandikayi C Matowe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

4.  Facilitation and inhibition of feeding by a single dose of amphetamine: relationship to baseline intake and accumbens cholecystokinin.

Authors:  T L Sills; F J Vaccarino
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.

Authors:  Ewa Gibula-Tarlowska; Jolanta H Kotlinska
Journal:  Biomolecules       Date:  2020-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.